截至要约收购报告书签署日，吴涛先生及其一致行动人已通过股份协议转让 收购公司 29.99996%股份及其对应的表决权，上市公司控股股东、实际控制人变 更为吴涛先生。同时，根据亚振投资及高伟先生、户美云女士、高银楠女士与吴 涛先生于 2025 年 4 月 24 日签署的《股份转让协议一之补充协议》约定，上海亚 振投资有限公司（以下简称"亚振投资"）及其一致行动人上海浦振投资管理有 限公司（以下简称"浦振投资"）、上海恩源投资管理有限公司（以下简称"上 海恩源"）不可撤销地承诺以其持有的公司共计 53,771,753 股股份（占上市公司 总股本的 20.4648%）有效申报预受要约，并自前述股份协议转让完成之日起至 本次要约收购完成之日止，放弃各自预受要约股份的表决权。 吴涛先生拟通过本次部分要约收购增加对上市公司的持股比例，进一步巩固 其对公司的控制权。 证券代码：603389 证券简称：*ST 亚振 公告编号：2025-042 亚振家居股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次要约收购期 ...

6月12日，亚振家居（证券简称*ST亚振）因股价近期大幅异常波动，于6月12日起停牌核查。GPLP犀牛财经注意到，亚振家居股票在5月6日至6月11日的连 续26个交易日内，17次触及涨停，日收盘价格涨幅偏离值累计高达107.83%，多次触及交易异常波动情形。 值得注意的是，亚振家居基本面并不支撑如此涨幅。该公司因连续3年亏损，且2024年营业收入低于3亿元，于4月30日被证监会实施退市风险警示 （*ST），经营状况严峻。 据了解，此轮股价狂飙的背景是亚振家居新实控人吴涛的入主。4月24日，亚振家居发布公告称，自然人吴涛计划通过"协议转让+部分要约收购"的方式取得 亚振家居控制权。随后，吴涛及其一致行动人范伟浩以4.48亿元总价、每股5.68元的价格，从原控股股东亚振投资处受让了公司30%的股权（其中吴涛占 24.54%）。该股权转让已于5月底完成过户，亚振家居控股股东及实际控制人正式变更为吴涛。 6月5日，吴涛进一步发出部分要约收购计划，拟在6月10日至7月9日期间，以同样的5.68元/股价格，向其他股东收购约5517.79万股（占总股本的21%）。若 收购成功，吴涛持股比例将升至51%，进一步巩固控制权。 ...

Core Viewpoint - The announcement details Mr. Cao Fei's tender offer to acquire shares of Hubei Jichuan Pharmaceutical Co., Ltd., with a focus on the acquisition's timeline, purpose, and conditions [2][3][4]. Group 1: Tender Offer Details - The tender offer is valid from June 18, 2025, to July 17, 2025, with specific conditions regarding the withdrawal of acceptance in the last three trading days [2][6][9]. - Mr. Cao Fei intends to acquire 350,841,357 shares, representing 38.06% of the total share capital of the company, at a price of 26.93 yuan per share [5][6]. - The payment method for the tender offer will be in cash [4][5]. Group 2: Purpose of the Tender Offer - The tender offer is a result of a share transfer agreement between Mr. Cao Longxiang and Mr. Cao Fei, where 10.10% of Jiangsu Jichuan Holding Group Co., Ltd. was transferred to Mr. Cao Fei for 10.1 million yuan, indicating a family restructuring of shareholding [2][3]. - The acquisition aims to fulfill the legal obligation for a comprehensive tender offer, and it does not intend to terminate the listing status of Jichuan Pharmaceutical [3]. Group 3: Procedures for Acceptance - Shareholders can submit their acceptance of the tender offer through designated securities companies during the offer period, with specific codes for the tender offer [7][8]. - Accepted shares will be temporarily held by China Securities Depository and Clearing Corporation Limited during the offer period, and shareholders cannot transfer these shares until the withdrawal process is completed [8][10]. Group 4: Additional Information - The company will provide updates on the progress of the tender offer and will issue a results announcement after the offer period ends [6][13]. - Investors seeking detailed information can refer to the tender offer report published on June 16, 2025, on the Shanghai Stock Exchange website [15].

Group 1 - The actual controller of Jichuan Pharmaceutical, Cao Longxiang, is transferring shares to his son, Cao Fei, which triggers a mandatory tender offer for the company [1][2] - Cao Fei will acquire 351 million shares, representing 38.06% of the total issued shares, with a maximum transaction value of 9.448 billion yuan [1][2] - Following the share transfer, Cao Fei's stake in Jichuan Holdings will increase to 60%, allowing him to indirectly control 517 million shares of Jichuan Pharmaceutical, exceeding the 30% threshold for a mandatory tender offer [2] Group 2 - Jichuan Pharmaceutical is facing significant pressure, with revenue and net profit declining for four consecutive quarters due to price cuts from centralized procurement [4] - In 2024, the company expects to achieve revenue of 8.017 billion yuan, a year-on-year decrease of 16.96%, and a net profit of 2.532 billion yuan, down 10.32% [4] - The company's sales expenses are high at 2.954 billion yuan, accounting for 36.85% of total revenue, while R&D expenses are only 445 million yuan, representing 5.55% of total revenue [4]

Group 1: New Stock Offerings - Jichuan Pharmaceutical (600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - *ST Yazhen (603389) has a tender offer period from June 10, 2025, to July 9, 2025[1] Group 2: Delisting Information - *ST Gongzhi (000584) will enter the delisting arrangement period starting June 20, 2025[1] - Delisting Haiyue (600387) has 14 trading days remaining until the last trading day[1] - Renle Tui (002336) has 13 trading days remaining until the last trading day[1] - Delisting Longyu (603003) has 10 trading days remaining until the last trading day[1] - Delisting Pengbo (600804) has 10 trading days remaining until the last trading day[1] - Longjin Tui (002750) has 8 trading days remaining until the last trading day[1] Group 3: Abnormal Fluctuations - Lianhua Technology (002250) reported severe abnormal fluctuations[1] - ST Kailin (002425) reported abnormal fluctuations[1] - ST Xianfeng (002141) reported abnormal fluctuations[1] - ST Shihuan (000518) reported abnormal fluctuations[1]

Core Viewpoint - The company has received a takeover offer from Mr. Cao Fei, which triggers a mandatory general offer due to the increase in shareholding above 30% [2][4]. Summary by Sections Offer Details - The offer price is set at 26.93 yuan per share, with a total of 350,841,357 shares being offered, representing 38.06% of the company's issued shares [4][5]. - The offer period lasts for 30 days, from June 18, 2025, to July 17, 2025, during which shareholders cannot withdraw their acceptance in the last three trading days [7]. Shareholding Changes - Mr. Cao Longxiang plans to transfer 10.10% of his shares in Jiangsu Jichuan Holding Group to his son, Mr. Cao Fei, making Mr. Cao Fei the controlling shareholder of Jichuan Holding with 60% ownership [2][4]. - Following the transfer, both Mr. Cao Fei and Mr. Cao Longxiang will be the joint actual controllers of the listed company, ensuring that the company's independence remains unaffected [2][4]. Financial Arrangements - The total maximum funding required for the offer is 18.95 billion yuan, with at least 20% of this amount deposited as a performance guarantee [6]. - The funding for the offer comes from the acquirer's own funds and legally raised funds, with no involvement from the listed company or its affiliates [6][7]. Compliance and Procedures - The acquirer, Mr. Cao Fei, does not require any authorization or approval from relevant institutions to make the offer [4]. - The offer is made in compliance with the Securities Law and the Takeover Management Measures, ensuring that the offer price is based on the weighted average price of the company's shares over the previous 30 trading days [5].

2025.06. 11 本文字数：978，阅读时长大约2分钟 作者 | 一财资讯 6月11日晚间，*ST亚振发布公告称，公司股票于5月6日至6月11日连续二十六个交易日内日收盘价 格涨幅偏离值累计达到107.83%，多次触及股票交易异常波动。公司股票短期涨幅与同期上证指 数、家具制造业存在严重偏离。为维护投资者利益，公司将就股票交易情况进行核查。 *ST亚振公告，2025年6月10日，公司所属家具制造业最新滚动市盈率为16.00，市净率为1.89， 公司最新滚动市盈率为亏损；市净率为13.88，严重高于同行业水准。可能存在市场情绪过热，非理 性炒作情形。公司郑重提醒广大投资者，公司股价可能存在短期涨幅较大后下跌的风险，请投资者务 必充分了解二级市场交易风险，切实提高风险意识，理性决策、审慎投资。 全国已有27个省份延长婚假 截至今日收盘，*ST亚振再度涨停。该股近期表现亮眼，5月股价累计涨幅93.14%，跻身5月月度十 大牛股之列。5月6日至6月11日，*ST亚振股价累计上涨111.60%。 公告显示，公司2024年度经审计的扣除非经常性损益后的净利润为负值，且扣除与主营业务无关的 业务收入和不具备商业实质的 ...

停牌核查。 6月11日晚间，*ST亚振（603389）发布关于股票交易风险提示暨停牌核查的公告。公告显示，公司股票于2025年5月6日至6月11日连续26个交易日内日收盘价格涨 幅偏离值累计达到107.83%，多次触及股票交易异常波动。公司股票短期涨幅与同期上证指数、家具制造业存在严重偏离。 为维护投资者利益，公司将就股票交易情况进行核查。经申请，公司股票自2025年6月12日开市起停牌，自披露核查公告后复牌，预计停牌时间不超过3个交易日。 | 证券代码 证券简称 | | 停留能英型 | 停牌起始日 | 停障 | 停牌终止日 | | | --- | --- | --- | --- | --- | --- | --- | | | | | | 期间 | | | | 603389 | *ST 亚提 | A 股 停牌 | 2025/6/12 | | | | 行情数据显示，*ST亚振股票自5月6日起曾连续10个交易日收盘涨停，此后，公司股票震荡上行，自本周来又开启连续涨停态势，本周三个交易日收盘均涨停。截 至今日（6月11日）收盘，公司股票自5月6日以来累计涨超111%。而若把时间再拉长，自今年4月8日盘中创下4.45 ...

Core Viewpoint - *ST Yazhen (SH603389) announced a stock suspension for verification starting June 12, 2025, following significant stock price fluctuations since May 2025, which raised concerns about potential risks of a price drop after a substantial increase [1][4]. Group 1: Stock Performance and Ownership Changes - Since May 2025, *ST Yazhen's stock price surged, with multiple instances of abnormal trading fluctuations [1]. - Wu Tao, a mining capital figure, acquired approximately 30% of *ST Yazhen's shares at a price of 5.68 yuan per share, resulting in a floating profit of about 128% as of June 11, 2025, amounting to over 500 million yuan in just seven trading days [3][6]. - The stock price increased from a low of 4.45 yuan on April 8, 2025, to 6.94 yuan by April 17, 2025, marking a rise of approximately 56% [6]. Group 2: Financial Performance and Risks - *ST Yazhen reported a negative net profit for the fiscal year 2024, with revenues excluding non-recurring items falling below 300 million yuan, leading to a delisting risk warning since May 6, 2025 [4]. - The company has experienced four consecutive years of losses, with a net loss exceeding 20 million yuan in the first quarter of 2025 [4]. - The company emphasized the need for investors to be aware of potential risks associated with the stock's short-term price fluctuations [4]. Group 3: Strategic Initiatives - In response to market challenges, *ST Yazhen aims to expand its market share in the mid-to-low-end product lines while leveraging existing industry resources for growth [5]. - The company has not identified any significant events or media reports that could have impacted its stock price, asserting that previous disclosures remain accurate [5].

公司股票短期涨幅与同期上证指数、家具制造业存在严重偏离。为维护投资者利益，公司将就股票交易情况进行核 查。 6月11日晚间，*ST亚振发布公告称，公司股票于5月6日至6月11日连续二十六个交易日内日收盘价格涨幅偏离值累计 达到107.83%，多次触及股票交易异常波动。公司股票短期涨幅与同期上证指数、家具制造业存在严重偏离。为维护 投资者利益，公司将就股票交易情况进行核查。 *ST亚振公告，2025年6月10日，公司所属家具制造业最新滚动市盈率为16.00，市净率为1.89，公司最新滚动市盈率为 亏损；市净率为13.88，严重高于同行业水准。可能存在市场情绪过热，非理性炒作情形。公司郑重提醒广大投资 者，公司股价可能存在短期涨幅较大后下跌的风险，请投资者务必充分了解二级市场交易风险，切实提高风险意识， 理性决策、审慎投资。 公告显示，公司2024年度经审计的扣除非经常性损益后的净利润为负值，且扣除与主营业务无关的业务收入和不具备 商业实质的收入后的营业收入低于3亿元，触及《上海证券交易所股票上市规则》第9.3.2条第一款第（一）项规定， 公司股票于2025年5月6日起实施退市风险警示。公司2025年第一季度营业 ...